UNIVERSITY OF FLORIDA

3D printing has revolutionized pediatric prosthetics, making them stronger, more personalized, and cost-effective. Limbitless Solutions, founded by UCF engineers, has donated bionic arms to 60 families, advancing technology and improving children's lives. The organization collaborates with partners to create expressive designs, enhancing both functionality and personality.

Art Bio Miami and The Global Passion Projects united art, science, and philanthropy during Art Basel week, showcasing transformative collaborations in healthcare and technology. Highlights included the Art Bio Gala, featuring pioneering research by Dr. Duane Mitchell, and discussions on quantum AI's potential in healthcare by Jack Hidary. The event also unveiled innovative health technologies and partnerships aimed at global health challenges.

Dr. Huang's lab studies prostate cancer genetics, focusing on African Americans. The Hollander Foundation awarded him $25,000 for research. Dr. Robert Hollander, a prostate cancer survivor and winemaker, funds the foundation to support prostate cancer research.

Genetesis launched CardioFlux Membership, offering regular heart scans at CardioFlux Imaging Institutes to monitor myocardial fitness via CardioFlux Score. The program coincides with the opening of their first institute in Mason, Ohio, with plans for national expansion. The CardioFlux Score, assessable only via Genetesis' CardioFlux MCG device, analyzes 14 biomarkers of heart muscle electrical activity. Memberships are available in three plans, with results accessible via personalized online accounts. Genetesis aims to prevent heart disease through regular heart health monitoring.

University of Arizona's research activity exceeded $1 billion in FY24, focusing on global challenges like energy, health, and national security. The university ranks among top research institutions and maintains its No. 1 ranking in astronomy and astrophysics. Research advances human knowledge, prepares students, and strengthens communities.

Iscalimab, a monoclonal antibody targeting an inflammatory pathway in Sjögren’s disease, showed improvements in clinician-reported disease activity and patient-reported dryness and fatigue in a Phase 2b trial, offering hope after prior drug failures.

Opus Genetics will host a virtual KOL event on Dec 11, 2024, to discuss 6-month efficacy and safety data on OPGx-LCA5, an AAV-based gene therapy for LCA5-associated IRD. Presenters include Jean Bennett, Tomas Aleman, Christine Kay, and Arshad Khanani, who will highlight the unmet need, development steps, and therapeutic potential. A live Q&A will follow.

Lungpacer Medical's AeroPace System, an FDA-approved neurostimulation therapy, aims to strengthen the diaphragm for quicker weaning from mechanical ventilation, offering faster recovery, reduced ventilator days, and lower reintubation risk.

Tryptamine Therapeutics completes Phase Ib trial of TRP-8803, an IV-infused psilocin formulation for obesity, with all participants safely discharged. Results will inform Phase II dose optimization.